Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.09.027Source: DataRank Database

Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation is a research paper published in Transplantation and Cellular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.89)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Sana Farooki ORCID,Elizabeth Klein ORCID,Audrey Mauguen ORCID,Susan E. Prockop ORCID,Andromachi Scaradavou ORCID

Live enrichment

PubMed:36210027 PMC:PMC9825630 OpenAlex:https://openalex.org/W4302287539

National Cancer Institute

Grant: P30 CA008748

NCI NIH HHS

Grant: P01 CA023766

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

FWCI

0.89

Citation Percentile

0.8%

Influential Citations

Citation Trend

2023

2024

2025

2026

greenLicense: CC BY NC ND

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9825630

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/9825630

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9825630

publisherhttps://api.elsevier.com/content/article/PII:S2666636722016669?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636722016669?httpAccept=text/plain

Fields of Study

Hematopoietic Stem Cell TransplantationChildhood Cancer Survivors' Quality of LifeCytomegalovirus and herpesvirus researchMedicine03 medical and health sciences0302 clinical medicineHumansChildRetrospective StudiesPeripheral Blood Stem CellsTransplantation, HomologousAntigens, CD34Graft vs Host DiseaseGranulocyte Colony-Stimulating Factor

MeSH Terms

Peripheral Blood Stem CellsChildGraft vs Host DiseaseHumansRetrospective StudiesTransplantation, HomologousGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell TransplantationAntigens, CD34

Keywords

MedicineStem cellCD34TransplantationSurgeryGranulocyte colony-stimulating factorHaematopoiesisHematopoietic stem cell transplantationBone marrowInternal medicineChemotherapyBiologyPediatric Allogeneic TransplantationCd34-selected Peripheral Blood Stem Cell BoostsPoor Graft Function (Pgf)Peripheral Blood Stem CellsHumansTransplantation, HomologousGraft vs Host DiseaseAntigens, CD34ChildRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: No poverty